In addition to our fully automatable Anti-SARS-CoV-2 ELISAs, we are pleased to complement our portfolio with the DEDIATEST 2019-nCoV-Antigen Rapid Test in cooperation with Devidia (Weimar, Germany).
Current News from our Company
Our SERION ELISA agile SARS-CoV-2 IgG was tested in an Independent study against 7 assays from competitors.
We are very happy to announce that the new SERION ELISA classic Dengue Virus superior IgM test will supplement our panel for the detection of tropical infectious diseases.
Concerning the global development of the Coronavirus (SARS-CoV-2), Institut Virion\Serion GmbH still assures the continuous supply of our products to our distributors and customers.
Institut Virion\Serion GmbH experienced four successful days in Dubai.